Ruesch Center Symposia


Did you miss one of the Ruesch Center Symposia? Catch up on the latest developments in GI cancer research, education and cure by viewing or listening to experts in the field of GI cancer discuss advancements in GI cancer care.

 

2013

December 6-7, 2013

The Ruesch Center for the Cure of Gastrointestinal Cancers held its fourth annual symposium devoted to the topic of molecular profiling to improve gastrointestinal cancer treatment and patient outcomes.  The Patient Symposium was focused on themes of interest to patients and their caregivers.

2012

November 30 and December 1, 2012

Fighting a Smarter War Against Cancer: Empowering Patients Through Clinical Trials, a two-part symposium brought to you by the Ruesch Center for the Cure of Gastrointestinal Cancers (part of Georgetown Lombardi Comprehensive Cancer Center). This symposium focused on the importance of clinical trials from the perspective of researchers, regulators, policymakers and patients.

2011

December 1-3, 2011

Fighting a Smarter War Against Cancer— Linking Policy to the Patient
The symposia brought top thought leaders and health care practitioners from the U.S. and around the world to discuss cancer care in relation to public policy, value and personalized medicine.

Available online:

 

2010

February 17, 2010
Fighting A Smarter War Against Cancer: Personalized Medicine and the Cure for Cancer


November 4, 2010
Ruesch Scientific Symposium: Molecular Diagnostics Drive Personalized Medicine

 

November 6, 2010
Ruesch Patient and Caregiver Community Outreach: Patient Education and Support

 

November 17, 2010
Ruesch Center International Symposium | Berne, Switzerland
The scientific symposia convened thought leaders in the fields of cancer research and personalized medicine, scientists, clinicians, advocates, and influencers in health care policy and bioethics, to discuss critical issues surrounding state-of-the-art biomarkers and molecular diagnostics. Issues that were addressed include Dr. Marshall's vision of personalized cancer care, contrasted with the "standard of care," where to look for biomarkers (tumor versus host), how to measure and validate these biomarkers, how to design clinical trials, and the ever-changing regulatory environment and bioethical implications of patient selection.

November 20, 2010
Ruesch Center International Symposium | Hamburg, Germany
The scientific symposia convened thought leaders in the fields of cancer research and personalized medicine, scientists, clinicians, advocates, and influencers in health care policy and bioethics, to discuss critical issues surrounding state-of-the-art biomarkers and molecular diagnostics. Issues that were addressed include Dr. Marshall's vision of personalized cancer care, contrasted with the "standard of care," where to look for biomarkers (tumor versus host), how to measure and validate these biomarkers, how to design clinical trials, and the ever-changing regulatory environment and bioethical implications of patient selection.